[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100337803":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":31,"responsibleParty":51,"collaborators":18,"id":53,"slug":18,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":18,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":76,"overallStatus":34,"whyStopped":18,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Centre Hospitalier Charles Perrens, Bordeaux","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Smartphone application","EXPERIMENTAL","This group of subjects receives mobile support system and conventional treatment (clinical evaluation and follow-up). The smartphone application will be downloaded on patients' smartphone to daily evaluate symptomatology, medication adherence…",[13],"Device: Smartphone Support System",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard services","NO_INTERVENTION","This group of patients receives conventional treatment only. Clinical evaluations are provided at the same endpoint. Patients still receive standard services for depression.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","Smartphone Support System","6 weeks smartphone application with daily evaluations",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"David MISDRAHI, M.D","CONTACT","+33(0)556563449","dmisdrahi@ch-perrens.fr",[32],{"facility":33,"status":34,"city":35,"state":18,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Centre Hospitalier Charles PERRENS","RECRUITING","Bordeaux","33076","France",{"type":39,"coordinates":40},"Point",[41,42],-0.58046,44.84124,{"lat":42,"lon":41},[45,47],{"name":27,"role":28,"phone":46,"phoneExt":18,"email":30},"003356563449",{"name":48,"role":28,"phone":49,"phoneExt":18,"email":50},"Helen SAVARIEAU, MSc","003356563556","hsavarieau@ch-perrens.fr",{"type":52,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100337803",false,"NCT03678194","Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application","Treating Depression on a Day-to-day Basis: Development of a Novel Clinical Tool for Physicians Based on a Smartphone Application, the SMART Project (Smartphones and Mood Disorders, an Application for Research and Treatment)","SMART","Inclusion Criteria:\n\n* Age between 18 and 65 years;\n* Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview;\n* Patients started their antidepressant treatment less than 5 days before inclusion;\n* Patient treated in an outpatient setting;\n* Patient informed of the diagnosis of his disease;\n* Informed patient with written consent.\n\nExclusion Criteria:\n\n* A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward;\n* A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features;\n* Cognitive deficit and not thus being able to comprehend the informed consent and study procedure;\n* Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….);\n* Non-comprehension of the French language","ALL","18 Years","65 Years",{"count":64,"type":65},200,"ESTIMATED","INTERVENTIONAL",[68],"NA","Testing and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.",[71,72,73,74,75],"Depression","Psychiatric Disorder","Brain Diseases","Central Nervous System Diseases","Nervous System Diseases",[71,77,78,79,80,81,82,83],"Smartphone","Relapse prevention","Mobile support system","eHealth","Ecological","Randomized","Multicentric","2026-03-13",{"date":86,"type":87},"2026-03-16","ACTUAL",{"date":89,"type":87},"2020-10-14",{"date":91,"type":65},"2026-12-31",{"name":5,"class":6},1]